Ligand Pharmaceuticals Incorporated (LGND)

Ligand Pharmaceuticals Incorporated (LGND) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $6.1B; returns 1 day -1.4%, 1 week +2.7%, 1 year +63.8%.

Ligand Pharmaceuticals Incorporated (LGND) is a biopharmaceutical company focused on acquiring and developing royalty-generating assets and technologies that help pharmaceutical companies discover and develop medicines. Its business model centers around drug discovery, early-stage drug development, product reformulation, and forming partnerships with other pharmaceutical companies.

Groups LGND belongs to

• Royalty Streams
• Biotechnology
• Biopharmaceutical
• Healthcare
• Life Sciences
• Drug Discovery
• Asset Management
• Commercial Stage
• Strategic Partnerships

LGND financial model: income statement, cash flow and balance sheet